The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
Open accessAbstract
Vaccines based on recombinant proteins avoid toxicity and anti-vector immunity associated with live vaccine (e.g., viral) vectors, but their immunogenicity is poor, particularly for CD8+ T-cell (CD8T) responses. Synthetic particles carrying antigens and adjuvant molecules have been developed to enhance subunit vaccines, but in general these materials have failed to elicit CD8T responses comparable to live vectors in preclinical animal models. Here, we describe interbilayer-crosslinked multilamellar vesicles (ICMVs) formed by crosslinking headgroups of adjacent lipid bilayers within multilamellar vesicles. ICMVs stably entrapped protein antigens in the vesicle core and lipid-based immunostimulatory molecules in the vesicle walls under extracellular conditions, but exhibited rapid release in the presence of endolysosomal lipases. We found that these antigen/adjuvant-carrying ICMVs form an extremely potent whole-protein vaccine, eliciting endogenous T-cell and antibody responses comparable to the strongest vaccine vectors. These materials should enable a range of subunit vaccines and provide new possibilities for protein therapeutic delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ellman, G. L. (1959) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(59)90090-6 · Cited by 26,311
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Central Memory and Effector Memory T Cell Subsets: Function, Generation, and Maintenance
Sallusto, F., Geginat, J., & Lanzavecchia, A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104702 · Cited by 3,067
Bioconjugation by Copper(I)-Catalyzed Azide-Alkyne [3 + 2] Cycloaddition
Wang, Q., Chan, T. R., Hilgraf, R., Fokin, V. V., Sharpless, K. B., & Finn, M. G. (2003) · Journal of the American Chemical Society · doi:10.1021/ja021381e · Cited by 1,641
Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,350
Mundargi, R. C., Babu, V. R., Rangaswamy, V., Patel, P., & Aminabhavi, T. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.013 · Cited by 1,025
The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4
Mata-Haro, V., Cekic, C., Martin, M., Chilton, P. M., Casella, C. R., & Mitchell, T. C. (2007) · Science · doi:10.1126/science.1138963 · Cited by 896
Porgador, A., Yewdell, J. W., Deng, Y., Bennink, J. R., & Germain, R. N. (1997) · Immunity · doi:10.1016/s1074-7613(00)80447-1 · Cited by 669
New horizons in adjuvants for vaccine development
Reed, S. G., Bertholet, S., Coler, R. N., & Friede, M. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.09.006 · Cited by 618
Materials engineering for immunomodulation
Hubbell, J. A., Thomas, S. N., & Swartz, M. A. (2009) · Nature · doi:10.1038/nature08604 · Cited by 561
Biodegradable nanoparticles for cytosolic delivery of therapeutics
VASIR, J., & LABHASETWAR, V (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.003 · Cited by 526
Cross-presentation in viral immunity and self-tolerance
Heath, W. R., & Carbone, F. R. (2001) · Nature Reviews Immunology · doi:10.1038/35100512 · Cited by 480
In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density
Zauner, W., Farrow, N. A., & Haines, A. M. R. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00358-8 · Cited by 411
Walker, B. D., & Burton, D. R. (2008) · Science · doi:10.1126/science.1152622 · Cited by 338
Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens
Perrie, Y., Mohammed, A. R., Kirby, D. J., McNeil, S. E., & Bramwell, V. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.036 · Cited by 333
Cycloadditions — Definition, Classification, and Characterization
Huisgen, R. (1968) · Angewandte Chemie International Edition in English · doi:10.1002/anie.196803211 · Cited by 320
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy
Demento, S. L., Eisenbarth, S. C., Foellmer, H. G., Platt, C., Caplan, M. J., Mark Saltzman, W., Mellman, I., Ledizet, M., Fikrig, E., Flavell, R. A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.034 · Cited by 290
How Do Adjuvants Work? Important Considerations for New Generation Adjuvants
McKee, A. S., Munks, M. W., & Marrack, P. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.003 · Cited by 263
Schlosser, E., Mueller, M., Fischer, S., Basta, S., Busch, D. H., Gander, B., & Groettrup, M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.01.030 · Cited by 262
Priddy, F. H., Brown, D., Kublin, J., Monahan, K., Wright, D. P., Lalezari, J., Santiago, S., Marmor, M., Lally, M., Novak, R. M., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587993 · Cited by 253
Molecular mechanisms of calcium-induced membrane fusion
Papahadjopoulos, D., Nir, S., & D�zg�nes, N. (1990) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf00762944 · Cited by 232
Kwon, Y. J., James, E., Shastri, N., & Fréchet, J. M. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509541102 · Cited by 201
Lutsiak, M. E. C., Robinson, D. R., Coester, C., Kwon, G. S., & Samuel, J. (2002) · Pharmaceutical Research · doi:10.1023/a:1020452531828 · Cited by 163
Antigen co‐encapsulated with adjuvants efficiently drive protective T cell immunity
Heit, A., Schmitz, F., Haas, T. L., Busch, D. H., & Wagner, H. (2007) · European Journal of Immunology · doi:10.1002/eji.200737169 · Cited by 147
Vaccine Delivery Methods Using Viral Vectors
Bråve, A., Ljungberg, K., Wahrén, B., & Liu, M. A. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060098+ · Cited by 139
Flatz, L., Hegazy, A. N., Bergthaler, A., Verschoor, A., Claus, C., Fernandez, M., Gattinoni, L., Johnson, S., Kreppel, F., Kochanek, S., et al. (2010) · Nature Medicine · doi:10.1038/nm.2104 · Cited by 139
Lysosomal Lipases of Rat Liver and Kidney
Mahadevan, S., & Tappel, A. L. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93349-1 · Cited by 135
In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes
Reddy, R., Zhou, F., Nair, S. K., Huang, L., & Rouse, B. T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.5.1585 · Cited by 129
Collins, D. S., Findlay, K. A., & Harding, C. V. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.11.3336 · Cited by 115
Liposomes as immunological adjuvants and vaccine carriers
Gregoriadis, G., Gürsel, İ., Gürsel, M., & McCormack, B. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(96)01355-7 · Cited by 100
Lyophilisation and sterilisation of liposomal vaccines to produce stable and sterile products
Mohammed, A. R., Bramwell, V. W., Coombes, A. G. A., & Perrie, Y. (2006) · Methods · doi:10.1016/j.ymeth.2006.05.025 · Cited by 95
Polymer-supported lipid shells, onions, and flowers
Bershteyn, A., Chaparro, J., Yau, R. G., Kim, M., Reinherz, E. L., Moita, L. F., & Irvine, D. J. (2008) · Soft Matter · doi:10.1039/b804933e · Cited by 92
Self-citationHeffernan, M. J., Kasturi, S. P., Yang, S. C., Pulendran, B., & Murthy, N. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.10.034 · Cited by 73
Haglund, K. E., Leiner, I. M., Kerksiek, K. M., Buonocore, L., Pamer, E. G., & Rose, J. K. (2002) · Journal of Virology · doi:10.1128/jvi.76.15.7506-7517.2002 · Cited by 68
Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen
Vangala, A., Bramwell, V. W., McNeil, S., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.010 · Cited by 54
Wakita, D., Chamoto, K., Zhang, Y., Narita, Y., Noguchi, D., Ohnishi, H., Iguchi, T., Sakai, T., Ikeda, H., & Nishimura, T. (2006) · International Immunology · doi:10.1093/intimm/dxh381 · Cited by 42
Steers, N. J., Peachman, K. K., McClain, S., Alving, C. R., & Rao, M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.105 · Cited by 37
Cited by
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C.-M. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,501
Designer vaccine nanodiscs for personalized cancer immunotherapy
Kuai, R., Ochyl, L. J., Bahjat, K. S., Schwendeman, A., & Moon, J. J. (2017) · Nature Materials · doi:10.1038/nmat4822 · Cited by 1,056
Self-citationZhao, L., Seth, A., Wibowo, N., Zhao, C.-X., Mitter, N., Yu, C., & Middelberg, A. P. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.069 · Cited by 919
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Self-citationFrom Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654
Metadata
- Authors
- Moon, J. J., Suh, H., Bershteyn, A., Stephan, M. T., Liu, H., Huang, B., Sohail, M., Luo, S., Ho Um, S., Khant, H., Goodwin, J. T., Ramos, J., Chiu, W., & Irvine, D. J.
- Venue
- Nature Materials
- Published
- 2011-02-20
- Volume
- 10
- Issue
- 3
- Pages
- 243-251
- ISSN
- 1476-1122 (ISSN-L)
- 1476-4660
- OpenAlex
- W1553974197
- Cited by
- 564
- References
- 39
- FWCI
- 14.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.